BSECompany Update5 Nov 2026 · 5 Nov 2026, 06:10 pm

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

AstraZeneca Pharma India Ltd · 506820

✦ AI SummaryMgmt Change

AstraZeneca Pharma India Ltd has updated the contact details of its key managerial personnel responsible for determining materiality of events and information for disclosure to stock exchanges, effective November 9, 2026.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

AstraZeneca Pharma India Ltd - 506820 - Determination Of Materiality - Details Of Key Managerial Personnel

Attachments (1)

📄

2eb79e16-fd68-4164-b715-b15c743f4bac.pdf

pdf

Download →
View document text
November 5, 2026 The Manager - Listing BSE Limited P J Towers, Dalal Street, Fort Mumbai - 400 001 BSE scrip code: 506820 The Manager - Listing National Stock Exchange of India Limited Exchange Plaza, Bandra – Kurla Complex, Bandra (E) Mumbai - 400 051 NSE symbol: ASTRAZEN Dear Sir/ Madam, Subject: Determination of materiality - Details of Key Managerial Personnel This is to inform that, as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the contact details of the Key Managerial Personnel authorised to determine the materiality of an event and/or information for disclosure to the Stock Exchange(s), with effect from November 9, 2026, are as follows: Sl. No. Name & Designation Contact Details 1. Mr. Praveen Rao Akkinepally Praveen.Akkinepally@astrazeneca.com Managing Director 2. Mr. Atul Tandon Atul.Tandon@astrazeneca.com Chief Financial Officer 3. Ms. Tanya Sanish tanya.sanish@astrazeneca.com Company Secretary Kindly take the above information on record. Thanking you, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer ACS No. A25784